Biosergen AB's total assets for Q1 2025 were kr47.32M, a decrease of -10.47% from the previous quarter. DE:8N1 total liabilities were kr3.90M for the fiscal quarter, a 5.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.